Prevalent serum antibody is not a marker of immune protection against acquisition of oncogenic HPV16 in men.
Lu B, Viscidi RP, Wu Y, Lee JH, Nyitray AG, Villa LL, Lazcano-Ponce E, da Silva RJ, Baggio ML, Quiterio M, Salmeron J, Smith DC, Abrahamsen ME, Papenfuss MR, Stockwell HG, Giuliano AR.
Lu B, et al. Among authors: smith dc.
Cancer Res. 2012 Feb 1;72(3):676-85. doi: 10.1158/0008-5472.CAN-11-0751. Epub 2011 Nov 28.
Cancer Res. 2012.
PMID: 22123925
Free PMC article.